Nu-Med Plus (NUMD) Interest Coverage Ratio Growth (1y) (2014 - 2025)
Nu-Med Plus (NUMD) Interest Coverage Ratio Growth (1y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.40 Bn | 176.11 Bn | 6.27 Bn | -45.18% |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 59.82% |
| 4 | Boston Scientific | 68.71 Bn | 67.25 Bn | 3.61 Bn | -80.85% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | 11.06% |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | 189.50% |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | -6.18% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -54.61% |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | 53.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 53.65% |
| Sep 30, 2025 | 61.46% |
| Jun 30, 2025 | 34.99% |
| Mar 31, 2025 | 8.10% |
| Dec 31, 2024 | 83.22% |
| Sep 30, 2024 | -14.99% |
| Jun 30, 2024 | 30.48% |
| Mar 31, 2024 | 24.56% |
| Dec 31, 2023 | -1,422,214.41% |
| Dec 31, 2022 | 94.30% |
| Dec 31, 2021 | 99.98% |
| Dec 31, 2020 | -1,561.02% |
| Sep 30, 2020 | -230.07% |
| Jun 30, 2020 | -505.88% |
| Mar 31, 2020 | 18.60% |
| Dec 31, 2019 | -190.11% |
| Sep 30, 2019 | -130.68% |
| Jun 30, 2019 | 59.05% |
| Mar 31, 2019 | -262.92% |
| Dec 31, 2018 | 115.20% |